Strategic funding Junction recently closed an 18M Series A led by Creandum with participation from YC, Point Nine, Amino Collective, and Inflect Health, signaling strong investor confidence and potential for scaled commercial partnerships with healthcare providers and digital health platforms.

Infrastructure leverage Position Junction as the backbone for hospitals and health care networks by highlighting its universal API that connects wearables, lab services, and medical devices, enabling scalable data integration for large health systems and multi-site clinics.

Clinical trial scale Suggested use case: offer Junction’s capability to scale data collection for clinical trials across distributed populations, targeting CROs, biotechs, and academic medical centers looking to streamline data capture from wearables and remote labs.

Patient experience Emphasize how Junction reduces operational burden from test ordering to results retrieval and supports patient-centric workflows (home lab kits, mobile phlebotomy), appealing to hospital operators aiming to improve patient experience and throughput.

Cross sell potential With traction in 50 states and integration with multiple devices and labs, target large health networks and payer organizations for bundled API access, coordinating care across chronic disease management, remote monitoring, and personalized treatment programs.